LAUREL BARNET: Open Payments
NPI 1427229970 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 88 payments from 24 companies in 2025. Trend: 2023 $1,962 · 2024 $1,678 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $442 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $210 |
| PFIZER INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 4 | $58 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $40 |
| Lilly USA, LLC | 2 | $32 |
Products named: VRAYLAR, Kerendia, UBRELVY, QULIPTA, REXULTI, TRELEGY ELLIPTA, HORIZANT, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
